Add to ORKGThe lipoproteins constitute valuable clinical diagnostic tools. This review will highlight the key clinical diagnostic aspects of the lipoprotein system at the phenotypic level; with the main focus on the following topics: (a) Structure and metabolism of lipoproteins. (b) Fluctuations in lipoprotein levels. (c) Lipoproteine (a). (d) Therapeutic treatment of hypercholesterolemias. The overall presentation aims to identify the most useful laboratory parameters that may help us evaluate the individual risk factor for the development of cardiological disease with greater accuracy
Atherosclerosis, the largest killer in the western world, arises from build-up of plaques at the art...
The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation ...
The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation ...
The effective reduction of atherogenic lipoproteins has contributed to the rate of atherosclerosis-r...
Lipoprotein(a) (Lp(a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to apolipo...
Advances in the causes of disorders of lipid metabolism, and effective intervention in atheroscleros...
The role of lipids is essential in any phase of the atherosclerotic process, which is considered a c...
The chemical structure of lipoprotein (a) is similar to that of LDL, from which it differs due to th...
Our review focuses on low density lipoprotein (LD lipoprotein) and very low density lipoprotein (VLD...
AbstractThere is a long history to our understanding of the biological basis of lipoproteins in card...
Elevated serum low-density lipoprotein cholesterol (LDLcholesterol) concentration is firmly establis...
Traditional lipid measures are the cornerstone of risk assessment and treatment goals in cardiovascu...
Cholesterol and lipoproteins, their impact (aspect) on human health The thesis is focused on cholest...
Background: Dyslipidaemias is a recognized risk factor for atherosclerosis, however, new evidence br...
In mammalian blood plasma there exist some 6 major lipoprotein classes. Under physiological conditio...
Atherosclerosis, the largest killer in the western world, arises from build-up of plaques at the art...
The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation ...
The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation ...
The effective reduction of atherogenic lipoproteins has contributed to the rate of atherosclerosis-r...
Lipoprotein(a) (Lp(a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to apolipo...
Advances in the causes of disorders of lipid metabolism, and effective intervention in atheroscleros...
The role of lipids is essential in any phase of the atherosclerotic process, which is considered a c...
The chemical structure of lipoprotein (a) is similar to that of LDL, from which it differs due to th...
Our review focuses on low density lipoprotein (LD lipoprotein) and very low density lipoprotein (VLD...
AbstractThere is a long history to our understanding of the biological basis of lipoproteins in card...
Elevated serum low-density lipoprotein cholesterol (LDLcholesterol) concentration is firmly establis...
Traditional lipid measures are the cornerstone of risk assessment and treatment goals in cardiovascu...
Cholesterol and lipoproteins, their impact (aspect) on human health The thesis is focused on cholest...
Background: Dyslipidaemias is a recognized risk factor for atherosclerosis, however, new evidence br...
In mammalian blood plasma there exist some 6 major lipoprotein classes. Under physiological conditio...
Atherosclerosis, the largest killer in the western world, arises from build-up of plaques at the art...
The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation ...
The joint consensus panel of the European Atherosclerosis Society (EAS) and the European Federation ...